Stamford, CT -- (SBWIRE) -- 01/02/2014 -- Jet Life Penny Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Rockwell Medical Inc (NASDAQ:RMTI), EXACT Sciences Corporation (NASDAQ:EXAS), Ellie Mae Inc (NYSE:ELLI), XOMA Corp (NASDAQ:XOMA)
Rockwell Medical Inc (NASDAQ:RMTI) opened the session at $10.82 trading in a range of $10.30 - $10.98. The stock showed a negative performance of -4.48% in the last trading session from its previous close of 10.93 and closed at $10.44. The stock traded on a volume of 1.43 million shares and the average volume of the stock remained 1.26 million shares. Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally. The company offers products and services for the treatment of end-stage renal disease, chronic kidney disease (CKD), iron deficiency, secondary hyperparathyroidism, and hemodialysis (HD). Its products are used to cleanse patients' blood and replace nutrients lost during the kidney dialysis process.
Has RMTI Found The Bottom and Ready To Move Up? Find Out Here
EXACT Sciences Corporation (NASDAQ:EXAS) traded 3.53 million shares in the last business day while the average volume of the stock remained 502,726 shares. The stock showed a negative movement of -4.32% to end at $11.75. The 52 week range of the stock remained $11.53 - $12.21. Exact Sciences Corporation, a molecular diagnostics company, focuses on developing diagnostic screening products for the early detection and prevention of colorectal pre-cancer and cancer. The company develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer.
Has EXAS Found The Bottom And Ready To Gain Momentum? Find Out Here
Ellie Mae Inc (NYSE:ELLI) reported 1.07 million shares were exchanged during the last trade, while the average volume is about 460,985 shares. The stock dropped -3.93% and finished the day at $26.87. Ellie Mae, Inc. and its subsidiaries provide business automation software for the mortgage industry in the United States. Its on-demand technology-enabled software solutions automate the process of originating and funding mortgage loans, facilitating regulatory compliance, and reducing documentation errors. The company provides Encompass, a proprietary software product that combines loan origination, business management, and customer relationship management software for mortgage originators, as well as provides access to the lenders and service providers on the Ellie Mae Network.
Why Should Investors Buy ELLI After the Recent Fall? Just Go Here and Find Out
XOMA Corp (NASDAQ:XOMA) shares dropped -3.17 percent from its previous close of $6.95 to close at $6.73. Traded with volume of 2.67 million shares in the prior session and the average volume of the stock remained 2.30 million shares. XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. The company offers ACEON, an angiotensin converting enzyme inhibitor. Its proprietary products include gevokizumab, a human engineering (HE) antibody to interleukin-1 beta, which is Phase III studies for non-infectious uveitis and Behçet?s uveitis; and Phase II studies for inflammatory acne, erosive osteoarthritis of the hand, active non-infectious anterior scleritis, and cardiovascular diseases.
Will XOMA Get Buyers Even After The Recent Rally? Find Out Here
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Our Penny Stock Newsletter also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Read full disclaimer at: http://www.jetlifepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)